Abstract
Both in endoscopic bariatric therapy and in post-bariatric surgical complications where the endoscopist is consulted and called up for help, the endoscopist may request earnestly the assistance of a surgeon, a true cross-pollination between two specialisms and two specialists.
Examples in endoscopic bariatric therapy are cases of perforation during balloon insertion or caused by the balloon itself during its residence in the stomach. The duodenojejunal bypass sleeve has certain complications such as device migration, gastrointestinal bleeding and liver abscess during their stay and complications due to mechanical trauma upon removal such as oesophageal perforation. For some endoscopic bariatric therapies, the endoscopist has to rely on laparoscopic assistance such as with ValenTx oesophagogastroduodenal bypass sleeve and with the incisionless magnetic anastomotic system to create a jejunoileal bypass. Eventually, we should consider the possibility of “third-stage complication”, i.e. first a surgical complication that is treated by the endoscopist, which may then be followed by a potential complication of the endoscopy that should be treated by surgery. Examples thereof are stent migration, perforation after endoscopic dilation of a surgical stenosis, an intractable stenosis after many endoscopic dilations that need surgery again, secondary abscesses after endoscopic drainage that cannot be approached by radiology and a persistent fistula despite all endoscopic measures.
In post-bariatric surgical complications the endoscopist, on his/her turn, needs the assistance of the surgeon, as for instance in the access to the excluded stomach and the biliary tree. Then two teams of surgeons and endoscopists are needed for the laparoscopy-assisted ERCP (LA-ERCP) and the laparoscopic transgastric rendez-vous (LATG-RV) procedure.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- BEA-ERCP:
-
Balloon enteroscopy-assisted ERCP
- DJBS:
-
Duodenojejunal bypass sleeve
- ERCP:
-
Endoscopic retrograde cholangiopancreaticography
- IMAS:
-
Incisionless magnetic anastomotic system
- IOP:
-
Incisionless Operating Platform
- LA-ERCP:
-
Laparoscopy-assisted ERCP
- LAGB:
-
Laparoscopic adjustable gastric banding
- LATG-RV:
-
Laparoscopic assisted transgastric rendez-vous
- POSE:
-
Primary Obesity Surgery Endoluminal
- RYGB:
-
Roux-en-Y gastric bypass
- SG:
-
Sleeve gastrectomy
- TERIS:
-
Transoral endoscopic restrictive implant system
References
Abou Hussein BM, Khammas AA, Al Ani AM, Swaleh AH, Al Awadhi SA, El Tayyeb YH, et al. Gastric perforation following intragastric balloon insertion: combined endoscopic and laparoscopic approach for management: case series and review of literature. Obes Surg. 2016;26:1127–32.
Mohamed Bekheit M, Abdelsalam WN, Sgromo B, Catheline J-M, Katri K. Is conservative management for gastric perforation secondary to intragastric balloon possible? Case report and review of literature. Obes Surg. 2014;24:968–70.
Mathus-Vliegen EMH. Is endoscopy really necessary for placing intragastric balloons? Obes Surg. 2018;28(1):169–75. https://doi.org/10.1007/s11695-017-2812-5.
Ponce J, Woodman G, Swain J, Wilson E, English W, REDUCE Pivotal Trial Investigators, et al. The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity. Surg Obes Relat Dis. 2015;11:874–81.
Mathus-Vliegen EMH, Tytgat GNJ. Intragastric balloons for morbid obesity: results, patient tolerance, and balloon life span. Br J Surg. 1990;77:76–9.
Sullivan S, Swain JM, Woodman G, Edmundowicz S, Hassanein TI, Shayani V, et al. 812d The Obalon swallowable 6-month balloon system is more effective than moderate intensity lifestyle therapy alone: results from a 6-month randomized sham controlled trial. Gastroenterology. 2016;150:S1267.
ASGE Bariatric Endoscopy Task Force and ASGE Technology Committee, Abu Dayyeh BK, Kumar N, Edmundowicz SA, Jonnalagadda S, Larsen M, et al. ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc. 2015;82:425–38.
Brethauer SA, Chang J, GalvaoNeto M, Greve JW. Gastrointestinal devices for the treatment of type 2 diabetes. Surg Obes Relat Dis. 2016;12:1256–61.
Vilarrasa N, Ruiz de Gordejuela AG, Casajoana A, Duran X, Toro S, Espinet E, et al. Endobarrier® in grade I obese patients with long-standing type 2 diabetes: role of gastrointestinal hormones in glucose metabolism. Obes Surg. 2017;27:569–77.
Tarnoff M, Rodriguez L, Escalona A, Ramos A, Neto M, Alamo M, et al. Open label, prospective, randomized controlled trial of an endoscopic duodenal-jejunal bypass sleeve versus low calorie diet for pre-operative weight loss in bariatric surgery. Surg Endosc. 2009;23:650–6.
Gersin KS, Rothstein RI, Rosenthal RJ, Stefanidis D, Deal SE, Kuwada TS, et al. Open-label, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates. Gastrointest Endosc. 2010;71:976–82.
Kaplan LM, Buse JB, Mullin C, Edmundo-Wicz S, Bass E, Visintainer P, et al. EndoBarrier therapy is associated with glycemic improvement, weight loss and safety issues in patients with obesity and type 2 diabetes on oral antihyperglycemic agents. Diabetes. 2016;65(suppl):A326–LB.
Lopez-Nava G, Galvão MP, da Bautista-Castaño I, Jimenez A, De Grado T, Fernandez-Corbelle JP. Endoscopic sleeve gastroplasty for the treatment of obesity. Endoscopy. 2015;47:449–52.
López-Nava G, Bautista-Castaño I, Jimenez A, de Grado T, Fernandez-Corbelle JP. The Primary Obesity Surgery Endolumenal (POSE) procedure: one-year patient weight loss and safety outcomes. Surg Obes Relat Dis. 2015;11:861–5.
Miller K, Turró R, Greve JW, Bakker CM, Buchwald JN, Espinós JC. MILEPOST multicenter randomized controlled trial: 12-month weight loss and satiety outcomes after posesm vs. medical therapy. Obes Surg. 2017;27:310–22.
Lopez-Nava G, Sharaiha RZ, Galvao Neto M, Kumta NA, Topazian M, Shukla A, et al. Endoscopic sleeve gastroplasty for obesity: a multicenter study of 242 patients with 18 months follow-up. Gastroenterology. 2016;150:S26.
Sullivan S, Swain JM, Woodman G, Antonetti M, De La Cruz-Munoz N, Jonnalagadda SS, et al. Randomized sham-controlled trial evaluating efficacy and safety of endoscopic gastric plication for primary obesity: the ESSENTIAL trial. Obesity. 2017;25:294–301.
Familiari P, Costamagna G, Blero D, Le Moine O, Perri V, Boskoski I, et al. Transoral gastroplasty for morbid obesity: a multicenter trial with a 1-year outcome. Gastrointest Endosc. 2011;74:1248–58.
de Jong K, Mathus-Vliegen EM, Veldhuyzen EA, Eshuis JH, Fockens P. Short-term safety and efficacy of the trans-oral endoscopic restrictive implant system for the treatment of obesity. Gastrointest Endosc. 2010;72:497–504.
Sandler BJ, Rumbaut R, Swain CP, Torres G, Morales L, Gonzales L, et al. One-year human experience with a novel endoluminal, endoscopic gastric bypass sleeve for morbid obesity. Surg Endosc. 2015;29:3298–303.
Machytka E, Bužga M, Zonca P, Lautz DB, Ryou M, Simonson DC, et al. Partial jejunal diversion using an incisionless magnetic anastomosis system: 1-year interim results in subjects with obesity and diabetes. Gastrointest Endosc. 2017;86(5):904–12. https://doi.org/10.1016/j.gie.2017.07.009.
Jones M, Healey AJ, Efthimiou E. Early use of self-expanding metallic stents to relieve sleeve gastrectomy stenosis after intragastric balloon removal. Surg Obes Relat Dis. 2011;7:e16–7.
de Goederen-van der Meij S, Pierik RG, Oudkerk PM, Gouma DJ, Mathus-Vliegen LM. Six months of balloon treatment does not predict the success of gastric banding. Obes Surg. 2007;17:88–94.
Khan O, Irukulla S, Sanmugalingam N, Vasilikostas G, Reddy M, Wan A. Simultaneous intra-gastric balloon removal and laparoscopic sleeve gastrectomy for the super-super obese patients — a prospective feasibility study. Obes Surg. 2013;23:585–7.
Rodriguez-Grunert L, Galvao Neto MP, Alamo M, Ramos AC, Baez PB, Tarnoff M. First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve. Surg Obes Relat Dis. 2008;4:55–9.
Schouten R, Rijs CS, Bouvy ND, Hameeteman W, Koek GH, Janssen IM, et al. A multicenter, randomized efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery. Ann Surg. 2010;251:236–43.
Ahuja NK, Nimgaonkar A. Precision Bariatrics: toward a new paradigm of personalized devices in obesity therapeutics. Obes Surg. 2016;26:1642–5.
Badaoui A, Malherbe V, Rosiere A, De Ronde T. ERCP by laparoscopic transgastric access and cholecystectomy at the same time in a patient with gastric bypass who was seen with choledocholithiasis. Gastrointest Endosc. 2010;71:212–4.
Bertin PM, Singh K, Arregui ME. Laparoscopic transgastric endoscopic retrograde cholangiopancreatography (ERCP) after gastric bypass: case series and a description of technique. Surg Endosc. 2011;25:2592–6.
Mejía R, Achurra P, Gabrielli M, Briceño E, Rebolledo R, Torres A, et al. Laparoscopy-assisted trans-gastric rendez-vous for the treatment of common bile duct stones in patients with prior Roux-en-Y gastric bypass. Obes Surg. 2016;26:2809–13.
Schreiner MA, Chang L, Gluck M, Irani S, Gan I, Brandabur JJ, et al. Laparoscopy–assisted versus balloon enteroscopy–assisted ERCP in bariatric post–Roux-en-Y gastric bypass patients. Gastrointest Endosc. 2012;75:748–56.
Gutierrez JM, Lederer H, Krook JC, Kinney TP, Freeman ML, Jensen EH. Surgical gastrostomy for pancreatobiliary and duodenal access following Roux-en-Y gastric bypass. J Gastrointest Surg. 2009;13:2170–5.
Tekola B, Wan AY, Ramanath M, Burnette B, Ellen K, Schirmer BD, et al. Percutaneous gastrostomy tube placement to perform transgastrostomy endoscopic retrograde cholangiopancreaticography in patients with Roux-en-Y anatomy. Dig Dis Sci. 2011;56:3364–9.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Mathus-Vliegen, E.M.H., Dargent, J. (2018). When the Endoscopist Needs the Surgeon. In: Bariatric Therapy. Springer, Cham. https://doi.org/10.1007/978-3-319-90074-2_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-90074-2_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-90073-5
Online ISBN: 978-3-319-90074-2
eBook Packages: MedicineMedicine (R0)